invIOs (private company)

See something wrong or missing? Let us know
Offices:Vienna
Business model:B2B

invIOs is a biotech startup in Austria spun off Apeiron in 2022 and focused on discovery and development of next-generation cancer therapies.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 9.1M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to invIOs

Name Criteria
Denmark Biograil
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Spain Cebiotex
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France Cell-Easy
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Norway Curida
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden Gradientech
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Denmark Octarine Bio
60%
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Austria Sarcura
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Spain ViveBiotech
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France PEP-Therapy
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Italy Harg
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Top